Varalakshmi, "Protective effects of certoparin
sodium, a low molecular weight heparin derivative, in experimental atherosclerosis," Clinica Chimica Acta, vol.
Tebbe et al., "A randomized, double-blind study of certoparin
(3.) Diener HC, Ringelstein EB, von Kummer R, et al Prophylaxis of thrombotic and embolic events in acute ischemic stroke with the low-molecular-weight heparin certoparin
: results of the PROTECT Trial.
All patients received initial therapy of subcutaneous LMWH, such as dalteparin, certoparin
(Sandoparin[R]), or enoxaparin.
LMWH preparations evaluated were certoparin
, dalteparin, enoxaparin, nadroparin, reviparin, and tinzaparin.